Fresenius Helios has celebrated the official groundbreaking for a new main building at HELIOS Hospital Dr. Horst Schmidt Kliniken in the German city of Wiesbaden. HELIOS is providing almost €200 million of the approximately €265 million total investment, with the rest coming from the state of Hesse. The seven-story structure will have some 96,000 square meters – about 1 million square feet – of floor space. The departments will be arranged using a functional design concept that minimizes distances for patients and staff. This will reduce waiting times. Completion is scheduled for 2020.
Fresenius Helios has opened the new building at its hospital in the northern German city of Schleswig. The 32,000-square-meter (344,000-square-foot) structure will accommodate up to 400 inpatients. Construction took two and a half years, with Fresenius Helios providing €30 million of the total investment sum of €80 million. The move from the existing facility into the new building will take place in mid-July.
Fresenius Helios has started work on the new main building at HELIOS St. Johannes Hospital in Duisburg, Germany. With about 25,000 square meters (270,000 square feet) of floor space, the five-story structure will house most of the medical departments, seven operating rooms, and 375 patient beds. The remaining beds will stay in the existing building, which will be completely renovated. The new building’s completion is planned for 2019. In the coming years, the company will invest about €110 million in the hospital.
Fresenius Helios completed today its acquisition of a 519-bed municipal hospital in the German state of North Rhine-Westphalia. Located in the city of Velbert, the hospital had 2015 sales of about €69 million. The acquisition, which was announced in February, will be accretive to Fresenius Group earnings from this year.
After nine months of construction, a new central sterilization unit has been opened at HELIOS Hospital Dr. Horst Schmidt Kliniken in Wiesbaden, Germany. Up to 75,000 medical instruments will be cleaned and sterilized annually in the unit, for use in five HELIOS hospitals. The total investment was about €4 million.

Fresenius Helios acquires the municipal hospital in Velbert located in the German state of North Rhine-Westphalia. The hospital has 519 beds and, with approximately 1,000 employees, treats 45,000 patients each year, including 20,000 inpatients. Sales were approximately €67 million in 2014.
Fresenius Helios will fully own the hospital. Following the acquisition, it plans to invest in a new, state-of-the-art hospital building. The facility is an excellent fit with the company’s existing presence and activities in North Rhine-Westphalia.
The acquisition is subject to approval by the German antitrust authorities. The parties agreed not to disclose the purchase price. The transaction is expected to close in the second quarter of 2016, and the hospital will already be accretive to Fresenius Group earnings starting this year.
This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Fresenius does not undertake any responsibility to update the forward-looking statements in this release.
Fresenius Helios acquires the municipal hospital in Velbert located in the German state of North Rhine-Westphalia. The hospital has 519 beds and, with approximately 1,000 employees, treats 45,000 patients each year, including 20,000 inpatients. Sales were approximately €67 million in 2014.
Fresenius Helios will fully own the hospital. Following the acquisition, it plans to invest in a new, state-of-the-art hospital building. The facility is an excellent fit with the company’s existing presence and activities in North Rhine-Westphalia.
The acquisition is subject to approval by the German antitrust authorities. The parties agreed not to disclose the purchase price. The transaction is expected to close in the second quarter of 2016, and the hospital will already be accretive to Fresenius Group earnings starting this year.
This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Fresenius does not undertake any responsibility to update the forward-looking statements in this release.
Fresenius Helios is celebrating the 40th anniversary of the HELIOS ENDO Hospital in Hamburg. This specialist center for bone, joint and spinal surgery treats some 7,000 patients annually. More than 140,000 joint implant and replacement procedures have been carried out at the hospital since its opening in 1976. Over €100 million has been invested in the hospital's modernization in recent years, and a new outpatient surgical department is scheduled to open in mid-2016.
Fresenius Helios has started expanding the HELIOS Amper Hospital in Dachau, near Munich. Within two years a new, multi-story extension will be completed. The existing building that houses the patient wards will then be completely renovated. When all the work is finished in four years, the hospital will have about 100 additional beds. The total investment is about €55 million.